The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key regions has introduced substantial uncertainty . Investors are now assessing the consequences of generic comp